MIRM Mirum Pharmaceuticals, Inc.
$85.81▲ +0.29%
Healthcare
Other
After hours
$85.72▼ -0.11%
Oct 28, 4:46 PM ET
Volume 535.2K
Avg Volume (10D) 594.4K
Key Metrics & Fundamentals
Market Cap
$5.57B
P/E Ratio
–
Div Yield
0.00%
52W Range
63.23 - 130.00
% vs 50 MA
-5.17%
% vs 200 MA
-12.99%
RSI-14
50.4
MACD Histogram
+0.9700
Beta (1Y vs SPY)
1.06
Free Cash Flow
-$69.28M
Gross Rev
$176.24M
Gross Profit
$145.90M
EBITDA
-$39.55M
COGS
$30.35M
Operating Exp
$172.00M
Operating Income
-$26.10M
EBIT
-$26.10M
Pretax Income
-$65.54M
Net Income
-$67.23M
EPS (Diluted)
-1.06
Price & Volume History
Loading chart…
Recent News
Recursion Pharmaceuticals (RXRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks · Oct 28, 2026 9:00 AM ET
Mirum Pharmaceuticals (MIRM) Stock Trades Near Fair Value As Pediatric FOP Study Progresses
Simply Wall St. · Oct 28, 2026 7:19 AM ET
Mirum Pharmaceuticals (MIRM) Could Be 44% Undervalued On Pediatric FOP Trial Data
Simply Wall St. · Oct 27, 2026 11:09 PM ET
Mirum Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 3, 2026
Business Wire · Oct 27, 2026 4:01 PM ET
Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks · Oct 27, 2026 9:00 AM ET
Mirum Pharmaceuticals Announces Positive Results from Cohort 2 of the Pivotal PROGRESS Study of ATEBRIOZ™ (zilurgisertib) in Pediatric Patients Aged 6 to <12 Years with Fibrodysplasia Ossificans Progressiva
Business Wire · Oct 26, 2026 6:50 PM ET
Mirum Drug Shows Promise Against Abnormal Bone Growth in Pediatric Phase 2 Trial
MT Newswires · Oct 26, 2026 9:15 AM ET
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
Business Wire · Oct 21, 2026 4:01 PM ET
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Oct 15, 2026 4:01 PM ET
Mirum's Livmarli Meets Phase III Goal in Ultra-Rare Liver Diseases
Zacks · Oct 13, 2026 9:41 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MIRM's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.